annual accounts payable:
$2.20B-$399.00M(-15.33%)Summary
- As of today (September 18, 2025), TEVA annual accounts payable is $2.20 billion, with the most recent change of -$399.00 million (-15.33%) on December 31, 2024.
- During the last 3 years, TEVA annual accounts payable has risen by +$517.00 million (+30.66%).
- TEVA annual accounts payable is now -41.14% below its all-time high of $3.74 billion, reached on December 31, 2011.
Performance
TEVA Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.50B+$208.03M(+9.08%)Summary
- As of today (September 18, 2025), TEVA quarterly accounts payable is $2.50 billion, with the most recent change of +$208.03 million (+9.08%) on June 30, 2025.
- Over the past year, TEVA quarterly accounts payable has increased by +$132.03 million (+5.58%).
- TEVA quarterly accounts payable is now -49.57% below its all-time high of $4.95 billion, reached on September 30, 2016.
Performance
TEVA quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TEVA Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | +5.6% |
| 3 y3 years | +30.7% | +31.4% |
| 5 y5 years | +28.2% | +55.5% |
TEVA Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | +30.7% | -4.0% | +52.8% |
| 5 y | 5-year | -15.3% | +30.7% | -4.0% | +65.0% |
| alltime | all time | -41.1% | +4689.3% | -49.6% | +3696.4% |
TEVA Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.50B(+9.1%) |
| Mar 2025 | - | $2.29B(+3.9%) |
| Dec 2024 | $2.20B(-15.3%) | $2.20B(-7.1%) |
| Sep 2024 | - | $2.37B(+0.2%) |
| Jun 2024 | - | $2.37B(-3.0%) |
| Mar 2024 | - | $2.44B(-6.3%) |
| Dec 2023 | $2.60B(+37.9%) | $2.60B(+14.1%) |
| Sep 2023 | - | $2.28B(-9.1%) |
| Jun 2023 | - | $2.51B(+5.3%) |
| Mar 2023 | - | $2.38B(+26.2%) |
| Dec 2022 | $1.89B(+11.9%) | $1.89B(+15.4%) |
| Sep 2022 | - | $1.64B(-14.0%) |
| Jun 2022 | - | $1.90B(+8.6%) |
| Mar 2022 | - | $1.75B(+3.8%) |
| Dec 2021 | $1.69B(-4.0%) | $1.69B(+11.4%) |
| Sep 2021 | - | $1.51B(-2.4%) |
| Jun 2021 | - | $1.55B(-8.3%) |
| Mar 2021 | - | $1.69B(-3.6%) |
| Dec 2020 | $1.76B(+2.2%) | $1.76B(+2.3%) |
| Sep 2020 | - | $1.72B(+6.8%) |
| Jun 2020 | - | $1.61B(-6.1%) |
| Mar 2020 | - | $1.71B(-0.5%) |
| Dec 2019 | $1.72B(-7.3%) | $1.72B(+1.8%) |
| Sep 2019 | - | $1.69B(-6.5%) |
| Jun 2019 | - | $1.81B(+2.4%) |
| Mar 2019 | - | $1.76B(-4.9%) |
| Dec 2018 | $1.85B(-10.4%) | $1.85B(+14.0%) |
| Sep 2018 | - | $1.63B(-8.6%) |
| Jun 2018 | - | $1.78B(-7.8%) |
| Mar 2018 | - | $1.93B(-6.8%) |
| Dec 2017 | $2.07B(-4.1%) | $2.07B(-12.7%) |
| Sep 2017 | - | $2.37B(+4.0%) |
| Jun 2017 | - | $2.28B(-4.2%) |
| Mar 2017 | - | $2.38B(+10.2%) |
| Dec 2016 | $2.16B(-40.0%) | $2.16B(-56.5%) |
| Sep 2016 | - | $4.95B(+28.5%) |
| Jun 2016 | - | $3.85B(+9.3%) |
| Mar 2016 | - | $3.53B(-1.8%) |
| Dec 2015 | $3.59B(+13.3%) | $3.59B(+21.3%) |
| Sep 2015 | - | $2.96B(-0.4%) |
| Jun 2015 | - | $2.98B(-2.0%) |
| Mar 2015 | - | $3.04B(-4.3%) |
| Dec 2014 | $3.17B(-4.4%) | $3.17B(+9.6%) |
| Sep 2014 | - | $2.89B(-4.4%) |
| Jun 2014 | - | $3.03B(-3.7%) |
| Mar 2014 | - | $3.14B(-5.2%) |
| Dec 2013 | $3.32B | $3.32B(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $3.05B(-1.9%) |
| Jun 2013 | - | $3.11B(-1.2%) |
| Mar 2013 | - | $3.14B(-6.9%) |
| Dec 2012 | $3.38B(-9.8%) | $3.38B(+9.0%) |
| Sep 2012 | - | $3.10B(+4.0%) |
| Jun 2012 | - | $2.98B(-6.0%) |
| Mar 2012 | - | $3.17B(-15.4%) |
| Dec 2011 | $3.74B(+49.2%) | $3.74B(+41.3%) |
| Sep 2011 | - | $2.65B(-0.5%) |
| Jun 2011 | - | $2.66B(+12.9%) |
| Mar 2011 | - | $2.36B(-6.1%) |
| Dec 2010 | $2.51B(-6.5%) | $2.51B(+0.3%) |
| Sep 2010 | - | $2.50B(+3.0%) |
| Jun 2010 | - | $2.43B(-7.7%) |
| Mar 2010 | - | $2.63B(-2.0%) |
| Dec 2009 | $2.68B(+18.5%) | $2.68B(+22.9%) |
| Sep 2009 | - | $2.18B(+2.2%) |
| Jun 2009 | - | $2.14B(+4.1%) |
| Mar 2009 | - | $2.05B(-9.3%) |
| Dec 2008 | $2.26B(+63.7%) | $2.26B(+50.3%) |
| Jun 2008 | - | $1.51B(+10.5%) |
| Mar 2008 | - | $1.36B(-1.4%) |
| Dec 2007 | $1.38B(+125.1%) | $1.38B(-57.7%) |
| Sep 2007 | - | $3.27B(+1.7%) |
| Jun 2007 | - | $3.21B(+3.0%) |
| Mar 2007 | - | $3.12B(+1549.9%) |
| Dec 2006 | $614.73M(+70.8%) | - |
| Dec 2005 | $359.87M(+0.3%) | - |
| Dec 2004 | $358.70M(+31.4%) | - |
| Dec 2003 | $272.94M(+8.6%) | - |
| Dec 2002 | $251.40M(+32.9%) | - |
| Dec 2001 | $189.11M(-57.2%) | $189.11M(-57.2%) |
| Dec 2000 | $442.23M(-6.9%) | $442.23M(+17.6%) |
| Jun 2000 | - | $375.91M(+52.6%) |
| Mar 2000 | - | $246.32M(+17.9%) |
| Dec 1999 | $474.98M(-7.7%) | - |
| Dec 1998 | $514.77M(+429.4%) | - |
| Sep 1998 | - | $208.90M(+29.6%) |
| Jun 1998 | - | $161.20M(-14.8%) |
| Mar 1998 | - | $189.10M(+3.7%) |
| Dec 1997 | $97.24M(-18.7%) | $182.40M(+1.1%) |
| Dec 1996 | $119.55M(+32.1%) | $180.50M(-1.6%) |
| Dec 1995 | $90.50M(+43.6%) | $183.50M(+80.6%) |
| Dec 1994 | $63.01M(+2.8%) | $101.60M(+0.1%) |
| Dec 1993 | $61.28M(+33.2%) | $101.50M(+38.9%) |
| Dec 1992 | $46.00M(-30.1%) | $73.10M(+11.1%) |
| Dec 1991 | $65.80M | $65.80M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual accounts payable?
- What is the all time high annual accounts payable for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual accounts payable year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly accounts payable year-on-year change?
What is Teva Pharmaceutical Industries Limited annual accounts payable?
The current annual accounts payable of TEVA is $2.20B
What is the all time high annual accounts payable for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual accounts payable is $3.74B
What is Teva Pharmaceutical Industries Limited annual accounts payable year-on-year change?
Over the past year, TEVA annual accounts payable has changed by -$399.00M (-15.33%)
What is Teva Pharmaceutical Industries Limited quarterly accounts payable?
The current quarterly accounts payable of TEVA is $2.50B
What is the all time high quarterly accounts payable for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly accounts payable is $4.95B
What is Teva Pharmaceutical Industries Limited quarterly accounts payable year-on-year change?
Over the past year, TEVA quarterly accounts payable has changed by +$132.03M (+5.58%)